A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
The purpose of this study is to describe patterns in disease management and to describe clinical outcomes, as well as to identify factors influencing physician treatment decisions including reason(s) for treatment choices and trigger(s) for treatment changes and to document healthcare resource utilization used to manage treatment-related complications.
Prostate Cancer|Castration-resistant Prostate Cancer|Metastatic Prostate Cancer
Patterns of disease management, Description of disease assessment methods, physician referral patterns and treatments, up to 72 months|Clinical outcomes, Evidence of disease progression and development of symptomatic disease, up to 72 months
Factors influencing physician treatment decisions, Reason/s for treatment choices and trigger/s for treatment changes, up to 72 months|Documentation of healthcare resource utilization used to manage treatment-related complications, up to 72 months
Each subject will be followed from the time of enrollment for a minimum of 3 years and a maximum of up to 6 years or until death, whichever comes first.